These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 19590965)

  • 1. Insights into the substrate specificity, inhibitors, regulation, and polymorphisms and the clinical impact of human cytochrome P450 1A2.
    Zhou SF; Yang LP; Zhou ZW; Liu YH; Chan E
    AAPS J; 2009 Sep; 11(3):481-94. PubMed ID: 19590965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure, function, regulation and polymorphism and the clinical significance of human cytochrome P450 1A2.
    Zhou SF; Wang B; Yang LP; Liu JP
    Drug Metab Rev; 2010 May; 42(2):268-354. PubMed ID: 19961320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthetic and natural compounds that interact with human cytochrome P450 1A2 and implications in drug development.
    Wang B; Zhou SF
    Curr Med Chem; 2009; 16(31):4066-218. PubMed ID: 19754423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights into the structure, function, and regulation of human cytochrome P450 1A2.
    Zhou SF; Chan E; Zhou ZW; Xue CC; Lai X; Duan W
    Curr Drug Metab; 2009 Sep; 10(7):713-29. PubMed ID: 19702529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism and Mechanism of Human Cytochrome P450 Enzyme 1A2.
    Guo J; Zhu X; Badawy S; Ihsan A; Liu Z; Xie C; Wang X
    Curr Drug Metab; 2021; 22(1):40-49. PubMed ID: 33397254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of the genetic polymorphism in the 5'-noncoding region of the CYP1A2 gene on CYP1A2 phenotype and urinary mutagenicity in smokers.
    Pavanello S; Pulliero A; Lupi S; Gregorio P; Clonfero E
    Mutat Res; 2005 Nov; 587(1-2):59-66. PubMed ID: 16188490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a high throughput single nucleotide polymorphism screening method for the cytochrome P450 1A2 polymorphisms CYP1A2*1C and CYP1A2*1F: are they useful as predictive markers in mental disorders?
    Klemm M; Eidens M; Lorenz M; Prause S; Weise A; Dahmen N; Forst T; Pfützner A
    Clin Lab; 2010; 56(9-10):473-80. PubMed ID: 21086794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cigarette smoking has a differential effect on the plasma level of clozapine in Taiwanese schizophrenic patients associated with the CYP1A2 gene -163A/C single nucleotide polymorphism.
    Huang HC; Lua AC; Wu LS; Wu BJ; Lee SM; Liu CZ
    Psychiatr Genet; 2016 Aug; 26(4):172-7. PubMed ID: 27203225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of genetic polymorphisms, smoking, gender and age on CYP1A2 activity in a Turkish population.
    Gunes A; Ozbey G; Vural EH; Uluoglu C; Scordo MG; Zengil H; Dahl ML
    Pharmacogenomics; 2009 May; 10(5):769-78. PubMed ID: 19450128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of CYP1A1/CYP1A2 and AHR polymorphisms on systemic olanzapine exposure.
    Söderberg MM; Haslemo T; Molden E; Dahl ML
    Pharmacogenet Genomics; 2013 May; 23(5):279-85. PubMed ID: 23492908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interindividual variation in relative CYP1A2/3A4 phenotype influences susceptibility of clozapine oxidation to cytochrome P450-specific inhibition in human hepatic microsomes.
    Zhang WV; D'Esposito F; Edwards RJ; Ramzan I; Murray M
    Drug Metab Dispos; 2008 Dec; 36(12):2547-55. PubMed ID: 18809730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid genotyping for relevant CYP1A2 alleles by pyrosequencing.
    Skarke C; Kirchhof A; Geisslinger G; Lötsch J
    Eur J Clin Pharmacol; 2005 Dec; 61(12):887-92. PubMed ID: 16307269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tizanidine is mainly metabolized by cytochrome p450 1A2 in vitro.
    Granfors MT; Backman JT; Laitila J; Neuvonen PJ
    Br J Clin Pharmacol; 2004 Mar; 57(3):349-53. PubMed ID: 14998432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of CYP1A2 activity in clinical practice: why, how, and when?
    Faber MS; Jetter A; Fuhr U
    Basic Clin Pharmacol Toxicol; 2005 Sep; 97(3):125-34. PubMed ID: 16128905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of human cytochrome P450 1A1-, 1A2-, and 1B1-mediated activation of procarcinogens to genotoxic metabolites by polycyclic aromatic hydrocarbons.
    Shimada T; Guengerich FP
    Chem Res Toxicol; 2006 Feb; 19(2):288-94. PubMed ID: 16485905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of genetic polymorphisms on CYP1A2 activity in humans: a systematic review and meta-analysis.
    Koonrungsesomboon N; Khatsri R; Wongchompoo P; Teekachunhatean S
    Pharmacogenomics J; 2018 Dec; 18(6):760-768. PubMed ID: 29282363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of heterologously expressed human cytochrome P450 1A2 to predict tacrine-fluvoxamine drug interaction in man.
    Becquemont L; Le Bot MA; Riche C; Funck-Brentano C; Jaillon P; Beaune P
    Pharmacogenetics; 1998 Apr; 8(2):101-8. PubMed ID: 10022747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between common CYP1A2 polymorphisms and theophylline metabolism in non-smoking healthy volunteers.
    Wang L; Hu Z; Deng X; Wang Y; Zhang Z; Cheng ZN
    Basic Clin Pharmacol Toxicol; 2013 Apr; 112(4):257-63. PubMed ID: 23167834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consumption of charcoal-broiled meat as an experimental tool for discerning CYP1A2-mediated drug metabolism in vivo.
    Larsen JT; Brøsen K
    Basic Clin Pharmacol Toxicol; 2005 Sep; 97(3):141-8. PubMed ID: 16128907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cytochrome P450 CYP1A2 genetic polymorphisms *1F and *1D do not affect clozapine clearance in a group of schizophrenic patients.
    Kootstra-Ros JE; Smallegoor W; van der Weide J
    Ann Clin Biochem; 2005 May; 42(Pt 3):216-9. PubMed ID: 15949157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.